Difference between revisions of "Cancer Types"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) |
|||
| (35 intermediate revisions by 4 users not shown) | |||
| Line 4: | Line 4: | ||
== Common Adult Cancers == | == Common Adult Cancers == | ||
| + | #[[:Category:AML|Acute Myeloid Leukemia]] | ||
| + | #[[:Category:Kidney|Neoplasms of the Kidney]] | ||
| + | #[[:Category:Brain|Neoplasms of the Brain and CNS]] | ||
| + | |||
== Common Pediatric Cancers == | == Common Pediatric Cancers == | ||
== WHO Classification of Tumours of the Central Nervous System (2016) == | == WHO Classification of Tumours of the Central Nervous System (2016) == | ||
| + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| + | '''CNS Tumors''' | ||
| + | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| Line 277: | Line 284: | ||
</div> | </div> | ||
'''Metastatic tumors''' | '''Metastatic tumors''' | ||
| + | </div> | ||
| + | </div> | ||
== WHO Classification of Pathology and Genetics of Head and Neck Tumors == | == WHO Classification of Pathology and Genetics of Head and Neck Tumors == | ||
| + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| + | '''Head and Neck Tumors''' | ||
| + | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| Line 284: | Line 296: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Malignant epithelial tumours | : Malignant epithelial tumours | ||
| − | : Squamous cell carcinoma | + | : [[Squamous cell carcinoma]] |
| − | : Lymphoepithelial carcinoma | + | : [[Lymphoepithelial carcinoma]] |
| − | : Sinonasal undifferentiated carcinoma | + | : [[Sinonasal undifferentiated carcinoma]] |
| − | : Adenocarcinoma | + | : [[Adenocarcinoma]] |
| − | : Salivary gland-type carcinomas | + | : [[Salivary gland-type carcinomas]] |
| − | : Neuroendocrine tumours | + | : [[Neuroendocrine tumours]] |
| − | : Benign epithelial tumours | + | : [[Benign epithelial tumours]] |
| − | : Schneiderian papillomas | + | : [[Schneiderian papillomas]] |
| − | : Respiratory epithelial adenomatoid hamartoma | + | : [[Respiratory epithelial adenomatoid hamartoma]] |
| − | : Salivary gland-type adenomas | + | : [[Salivary gland-type adenomas]] |
| − | : Soft tissue tumours | + | : [[Soft tissue tumours]] |
| − | : Malignant soft tissue tumours | + | : [[Malignant soft tissue tumours]] |
| − | : Borderline and LMP tumours | + | : [[Borderline and LMP tumours]] |
| − | : Benign soft tissue tumours | + | : [[Benign soft tissue tumours]] |
| − | : Tumours of bone and cartilage | + | : [[Tumours of bone and cartilage]] |
| − | : Malignant tumours | + | : [[Malignant tumours]] |
| − | : Benign tumours | + | : [[Benign tumours]] |
| − | : Haematolymphoid tumours | + | : [[Haematolymphoid tumours]] |
| − | : Neuroectodermal tumours | + | : [[Neuroectodermal tumours]] |
| − | : Germ cell tumours | + | : [[Germ cell tumours]] |
| − | : Secondary tumours | + | : [[Secondary tumours]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 497: | Line 509: | ||
: Vagal paraganglioma | : Vagal paraganglioma | ||
: Laryngeal paraganglioma | : Laryngeal paraganglioma | ||
| + | </div> | ||
| + | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 503: | Line 517: | ||
== WHO Classification of Tumors of Endocrine Organs == | == WHO Classification of Tumors of Endocrine Organs == | ||
| + | |||
| + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| + | '''Endocrine Tumors''' | ||
| + | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| Line 609: | Line 627: | ||
:McCune-Albright syndrome | :McCune-Albright syndrome | ||
:Familial non-medullary thyroid cancer | :Familial non-medullary thyroid cancer | ||
| + | </div> | ||
| + | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 620: | Line 640: | ||
== WHO Classification of Tumors of the Breast (2012) == | == WHO Classification of Tumors of the Breast (2012) == | ||
| + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| + | '''Breast Tumors''' | ||
| + | <div class="mw-collapsible-content"> | ||
'''Invasive carcinoma of no special type (invasive ductal carcinoma)''' | '''Invasive carcinoma of no special type (invasive ductal carcinoma)''' | ||
| − | |||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
'''Special subtypes''' | '''Special subtypes''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Invasive lobular carcinoma | + | : [[Invasive lobular carcinoma]] |
| − | : Tubular carcinoma and cribriform carcinoma | + | : [[Tubular carcinoma]] and [[cribriform carcinoma]] |
| − | : Carcinoma with medullary features | + | : [[Carcinoma with medullary features]] |
| − | : Metaplastic carcinoma | + | : [[Metaplastic carcinoma]] |
| − | : Carcinoma with apocrine differentiation | + | : [[Carcinoma with apocrine differentiation]] |
| − | : Salivary gland/skin adnexal type tumors | + | : [[Salivary gland/skin adnexal type tumors]] |
| − | : Adenoid cystic carcinoma | + | : [[Adenoid cystic carcinoma]] |
| − | : Mucoepidermoid carcinoma | + | : [[Mucoepidermoid carcinoma]] |
| − | : Polymorphous carcinoma | + | : [[Polymorphous carcinoma]] |
| − | : Mucinous carcinoma and | + | : [[Mucinous carcinoma]] and [[Carcinoma with signet-ring-cell differentiation]] |
| − | + | : [[Carcinoma with neuroendocrine features]] | |
| − | : Invasive papillary carcinoma | + | : [[Invasive papillary carcinoma]] |
| − | : Invasive micropapillary carcinoma | + | : [[Invasive micropapillary carcinoma]] |
| − | : Inflammatory carcinoma | + | : [[Inflammatory carcinoma]] |
: Bilateral breast carcinoma and non-synchronous breast carcinoma | : Bilateral breast carcinoma and non-synchronous breast carcinoma | ||
| − | : Secretory carcinoma | + | : [[Secretory carcinoma]] |
| − | : Oncocytic carcinoma | + | : [[Oncocytic carcinoma]] |
| − | : Sebaceous carcinoma | + | : [[Sebaceous carcinoma]] |
| − | : Lipid-rich carcinoma | + | : [[Lipid-rich carcinoma]] |
| − | : Glycogen-rich clear cell carcinoma | + | : [[Glycogen-rich clear cell carcinoma]] |
| − | : Acinic cell carcinoma | + | : [[Acinic cell carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 657: | Line 679: | ||
: Columnar cell lesions | : Columnar cell lesions | ||
: Atypical ductal hyperplasia | : Atypical ductal hyperplasia | ||
| − | : Ductal carcinoma in situ | + | : [[Ductal carcinoma in situ]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 666: | Line 688: | ||
'''Intraductal papillary lesions''' | '''Intraductal papillary lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Intraductal papilloma | + | : [[Intraductal papilloma]] |
| − | : Intraductal papillary carcinoma | + | : [[Intraductal papillary carcinoma]] |
| − | : Encapsulated papillary carcinoma | + | : [[Encapsulated papillary carcinoma]] |
| − | : Solid papillary carcinoma | + | : [[Solid papillary carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 676: | Line 698: | ||
'''Benign epithelial proliferations''' | '''Benign epithelial proliferations''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Adenosis, sclerosing adenosis and | + | : Adenosis, sclerosing adenosis and apocrine adenosis |
| − | + | : [[Microglandular adenosis]],[[atypical microglandular adenosis and microglandular adenosis with carcinoma]] | |
| − | : Microglandular adenosis, | + | : [[Radial scar and complex sclerosing lesion]] |
| − | + | : [[Tubular adenoma]] | |
| − | |||
| − | : Radial scar and complex sclerosing lesion | ||
| − | : Tubular adenoma | ||
: Lactating adenoma | : Lactating adenoma | ||
: Apocrine adenoma | : Apocrine adenoma | ||
| Line 693: | Line 712: | ||
'''Myoepithelial and epithelial–myoepithelial lesions''' | '''Myoepithelial and epithelial–myoepithelial lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Myoepithelial and epithelial–myoepithelial lesions | + | : [[Myoepithelial and epithelial–myoepithelial lesions]] |
| − | : Adenomyoepithelioma and adenomyoepithelioma with carcinoma | + | : [[Adenomyoepithelioma and adenomyoepithelioma with carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 703: | Line 722: | ||
: Nodular fasciitis | : Nodular fasciitis | ||
: Benign vascular lesions | : Benign vascular lesions | ||
| − | : Pseudoangiomatous stromal hyperplasia | + | : [[Pseudoangiomatous stromal hyperplasia]] |
| − | : Myofibroblastoma | + | : [[Myofibroblastoma]] |
| − | : Desmoid-type fibromatosis | + | : [[Desmoid-type fibromatosis]] |
: Inflammatory myofibroblastic tumour | : Inflammatory myofibroblastic tumour | ||
: Lipoma | : Lipoma | ||
: Granular cell tumour and benign peripheral | : Granular cell tumour and benign peripheral | ||
: nerve-sheath tumour | : nerve-sheath tumour | ||
| − | : Angiosarcoma | + | : [[Angiosarcoma]] |
: Liposarcoma | : Liposarcoma | ||
: Rhabdomyosarcoma | : Rhabdomyosarcoma | ||
| Line 721: | Line 740: | ||
'''Fibroepithelial tumors''' | '''Fibroepithelial tumors''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Fibroadenoma | + | : [[Fibroadenoma]] |
| − | : Phyllodes tumour | + | : [[Phyllodes tumour]] |
: Hamartoma | : Hamartoma | ||
</div> | </div> | ||
| Line 732: | Line 751: | ||
: Nipple adenoma | : Nipple adenoma | ||
: Syringomatous tumour | : Syringomatous tumour | ||
| − | : Paget disease | + | : [[Paget disease]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 739: | Line 758: | ||
'''Lymphoid and haematopoietic tumors''' | '''Lymphoid and haematopoietic tumors''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Diffuse large B-cell lymphoma | + | : [[Diffuse large B-cell lymphoma]] |
: Burkitt lymphoma | : Burkitt lymphoma | ||
: T-cell lymphoma | : T-cell lymphoma | ||
| Line 752: | Line 771: | ||
'''Tumors of the male breast''' | '''Tumors of the male breast''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | : Gynaecomastia | + | : [[Gynaecomastia]] |
| − | : Carcinoma of the male breast | + | : [[Carcinoma of the male breast]] |
</div> | </div> | ||
</div> | </div> | ||
| Line 761: | Line 780: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Inherited syndromes associated with an increased risk of breast cancer: Introduction | : Inherited syndromes associated with an increased risk of breast cancer: Introduction | ||
| − | : BRCA1 and BRCA2 | + | : [[BRCA1 symdrome]] and [[BRCA2 syndrome]] |
| − | : Li-Fraumeni syndrome | + | : [[Li-Fraumeni syndrome]] |
: Ataxia telangiectasia syndrome | : Ataxia telangiectasia syndrome | ||
: Cowden syndrome | : Cowden syndrome | ||
: Lynch syndrome | : Lynch syndrome | ||
: Other breast cancer-predisposing genes | : Other breast cancer-predisposing genes | ||
| + | </div> | ||
| + | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 773: | Line 794: | ||
== WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == | == WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == | ||
| + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| + | '''[[Hematological and Lymphoid Neoplasms]]''' | ||
| + | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Myeloproliferative neoplasms''' | + | '''[[Myeloproliferative neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Chronic myelogenous leukaemia, BCR-ABL1 positive | + | :[[Chronic myelogenous leukaemia, BCR-ABL1 positive]] |
| − | :Chronic neutrophilic leukaemia | + | :[[Chronic neutrophilic leukaemia]] |
| − | :Polycythaemia vera | + | :[[Polycythaemia vera]] |
| − | :Primary myelofibrosis | + | :[[Primary myelofibrosis]] |
| − | :Essential thrombocythaemia | + | :[[Essential thrombocythaemia]] |
| − | :Chronic eosinophilic leukaemia, NOS | + | :[[Chronic eosinophilic leukaemia, NOS]] |
| − | :Mastocytosis | + | :[[HAEM4:Mastocytosis]] |
| − | :Cutaneous mastocytosis | + | :[[Cutaneous mastocytosis]] |
| − | :Systemic mastocytosis | + | :[[Systemic mastocytosis]] |
| − | :Mast cell leukaemia | + | :[[Mast cell leukaemia]] |
| − | :Mast cell sarcoma | + | :[[Mast cell sarcoma]] |
| − | :Extracutaneous mastocytoma | + | :[[Extracutaneous mastocytoma]] |
| − | :Myeloproliferative neoplasm, unclassifiable | + | :[[Myeloproliferative neoplasm, unclassifiable]] |
</div> | </div> | ||
</div> | </div> | ||
| − | '''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1''' | + | '''[[Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1]] |
| + | ''' | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Myelodysplastic/myeloproliferative neoplasms''' | + | '''[[Myelodysplastic/myeloproliferative neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Chronic myelomonocytic leukaemia | + | :[[Chronic myelomonocytic leukaemia]] |
| − | :Atypical chronic myeloid leukaemia, BCR-ABL1 negative | + | :[[Atypical chronic myeloid leukaemia, BCR-ABL1 negative]] |
| − | :Juvenile myelomonocytic leukaemia | + | :[[Juvenile myelomonocytic leukaemia]] |
| − | :Myelodysplastic/myeloproliferative neoplasm, unclassifiable | + | :[[Myelodysplastic/myeloproliferative neoplasm, unclassifiable]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Myelodysplastic syndromes''' | + | '''[[Myelodysplastic syndromes]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Myelodysplastic syndromes/neoplasms, overview | + | :[[Myelodysplastic syndromes/neoplasms, overview]] |
| − | :Refractory cytopenia with unilineage dysplasia | + | :[[Refractory cytopenia with unilineage dysplasia]] |
| − | :Refractory anaemia with ring sideroblasts | + | :[[Refractory anaemia with ring sideroblasts]] |
| − | :Refractory cytopenia with multilineage dysplasia | + | :[[Refractory cytopenia with multilineage dysplasia]] |
| − | :Refractory anaemia with excess blasts | + | :[[Refractory anaemia with excess blasts]] |
| − | :Myelodysplastic syndrome with isolated del(5q) | + | :[[Myelodysplastic syndrome with isolated del(5q)]] |
| − | :Myelodysplastic syndrome, unclassifiable | + | :[[Myelodysplastic syndrome, unclassifiable]] |
| − | :Childhood myelodysplastic syndrome | + | :[[Childhood myelodysplastic syndrome]] |
| − | :Refractory cytopenia of childhood | + | :[[Refractory cytopenia of childhood]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Acute myeloid leukaemia (AML) and related precursor neoplasms''' | + | '''[[Acute myeloid leukaemia (AML) and related precursor neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :AML with recurrent genetic abnormalities | + | :[[AML with recurrent genetic abnormalities]] |
| − | :AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 | + | :[[AML with t(8;21)(q22;q22); RUNX1-RUNX1T1]] |
| − | :AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | + | :[[AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
| − | :Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA | + | :[[Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA]] |
| − | :AML with t(9;11)(p22;q23); MLLT3-MLL | + | :[[AML with t(9;11)(p22;q23); MLLT3-MLL]] |
| − | :AML with t(6;9)(p23;q34); DEK- | + | :[[AML with t(6;9)(p23;q34); DEK-NUP214]] |
| − | :AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 | + | :[[AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1]] |
| − | :AML with mutated NPM1 | + | :[[AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1]] |
| − | :AML with mutated CEBPA | + | :[[AML with mutated NPM1]] |
| − | :AML with myelodysplasia-related changes | + | :[[AML with mutated CEBPA]] |
| − | :Therapy-related myeloid neoplasms | + | :[[AML with myelodysplasia-related changes]] |
| − | :Acute myeloid leukaemia, NOS | + | :[[Therapy-related myeloid neoplasms]] |
| − | :AML with minimal differentiation | + | :[[Acute myeloid leukaemia, NOS]] |
| − | :AML without maturation | + | :[[AML with minimal differentiation]] |
| − | :AML with maturation | + | :[[AML without maturation]] |
| − | :Acute myelomonocytic leukaemia | + | :[[AML with maturation]] |
| − | :Acute monoblastic and monocytic leukaemia | + | :[[Acute myelomonocytic leukaemia]] |
| − | :Acute erythroid leukaemia | + | :[[Acute monoblastic and monocytic leukaemia]] |
| − | :Acute megakaryoblastic leukaemia | + | :[[Acute erythroid leukaemia]] |
| − | :Acute basophilic leukaemia | + | :[[Acute megakaryoblastic leukaemia]] |
| − | :Acute panmyelosis with myelofibrosis | + | :[[Acute basophilic leukaemia]] |
| − | :Myeloid sarcoma | + | :[[Acute panmyelosis with myelofibrosis]] |
| − | :Myeloid proliferations related to Down syndrome | + | :[[Myeloid sarcoma]] |
| − | :Transient abnormal myelopoiesis | + | :[[Myeloid proliferations related to Down syndrome]] |
| − | :Myeloid leukaemia associated with Down syndrome | + | :[[Transient abnormal myelopoiesis]] |
| − | :Blastic plasmacytoid dendritic cell neoplasm | + | :[[Myeloid leukaemia associated with Down syndrome]] |
| + | :[[Blastic plasmacytoid dendritic cell neoplasm]] | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Acute leukaemias of ambiguous lineage''' | + | '''[[Acute leukaemias of ambiguous lineage]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Acute undifferentiated leukaemia | + | :[[Acute undifferentiated leukaemia]] |
| − | :Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 | + | :[[Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1]] |
| − | :Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged | + | :[[Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged]] |
| − | :Mixed phenotype acute leukaemia, B/myeloid, NOS 152 | + | :[[Mixed phenotype acute leukaemia, B/myeloid, NOS]] 152 |
| − | :Mixed phenotype acute leukaemia, T/myeloid, NOS 153 | + | :[[Mixed phenotype acute leukaemia, T/myeloid, NOS]] 153 |
| − | :Mixed phenotype acute leukaemia, NOS - rare types | + | :[[Mixed phenotype acute leukaemia, NOS - rare types]] |
| − | :Other ambiguous lineage leukaemias | + | :[[Other ambiguous lineage leukaemias]] |
| − | :Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma | + | :[[Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Precursor lymphoid neoplasms''' | + | '''[[Precursor lymphoid neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :B lymphoblastic leukaemia/lymphoma, NOS | + | :[[B lymphoblastic leukaemia/lymphoma, NOS]] |
| − | :B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities | + | :[[B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities]] |
| − | :B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1 | + | :[[B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1]] |
| − | :B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged | + | :[[B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged]] |
| − | :B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) | + | :[[B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)]] |
| − | :B lymphoblastic leukaemia/lymphoma with hyperdiploidy | + | :[[B lymphoblastic leukaemia/lymphoma with hyperdiploidy]] |
| − | :B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) | + | :[[B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)]] |
| − | :B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH | + | :[[B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH]] |
| − | :B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1) | + | :[[B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)]] |
| − | :T lymphoblastic leukaemia/lymphoma | + | :[[T lymphoblastic leukaemia/lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Mature B-cell neoplasms''' | + | '''[[Mature B-cell neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Chronic lymphocytic leukaemia /small lymphocytic lymphoma | + | :[[Chronic lymphocytic leukaemia /small lymphocytic lymphoma]] |
| − | :B-cell prolymphocytic leukaemia | + | :[[B-cell prolymphocytic leukaemia]] |
| − | :Splenic marginal zone lymphoma | + | :[[Splenic marginal zone lymphoma]] |
| − | :Hairy cell leukaemia | + | :[[Hairy cell leukaemia]] |
| − | :Splenic B-cell lymphoma/leukaemia, unclassifiable | + | :[[Splenic B-cell lymphoma/leukaemia, unclassifiable]] |
| − | :Splenic diffuse red pulp small B-cell lymphoma | + | :[[Splenic diffuse red pulp small B-cell lymphoma]] |
| − | :Hairy cell leukaemia-variant | + | :[[Hairy cell leukaemia-variant]] |
| − | :Lymphoplasmacytic lymphoma | + | :[[Lymphoplasmacytic lymphoma]] |
| − | :Heavy chain diseases | + | :[[Heavy chain diseases]] |
| − | :Gamma heavy chain disease | + | :[[Gamma heavy chain disease]] |
| − | :Mu heavy chain disease | + | :[[Mu heavy chain disease]] |
| − | :Alpha heavy chain disease | + | :[[Alpha heavy chain disease]] |
| − | :Plasma cell neoplasms | + | :[[Plasma cell neoplasms]] |
| − | :Monoclonal gammopathy of undetermined significance (MGUS) | + | :[[Monoclonal gammopathy of undetermined significance (MGUS)]] |
| − | :Plasma cell myeloma | + | :[[Plasma cell myeloma]] |
| − | :Solitary plasmacytoma of bone | + | :[[Solitary plasmacytoma of bone]] |
| − | :Extraosseous plasmacytoma | + | :[[Extraosseous plasmacytoma]] |
| − | :Monoclonal immunoglobulin deposition diseases | + | :[[Monoclonal immunoglobulin deposition diseases]] |
| − | :Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma) | + | :[[Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)]] |
| − | :Nodal marginal zone lymphoma | + | :[[Nodal marginal zone lymphoma]] |
| − | :Follicular lymphoma | + | :[[Follicular lymphoma]] |
| − | :Primary cutaneous follicle centre lymphoma | + | :[[Primary cutaneous follicle centre lymphoma]] |
| − | :Mantle cell lymphoma | + | :[[Mantle cell lymphoma]] |
| − | :Diffuse large B-cell lymphoma (DLBCL), NOS | + | :[[Diffuse large B-cell lymphoma (DLBCL), NOS]] |
| − | :T cell/histiocyte-rich large B-cell lymphoma | + | :[[T cell/histiocyte-rich large B-cell lymphoma]] |
| − | :Primary DLBCL of the CNS | + | :[[Primary DLBCL of the CNS]] |
| − | :Primary cutaneous DLBCL, leg type | + | :[[Primary cutaneous DLBCL, leg type]] |
| − | :EBV positive DLBCL of the elderly | + | :[[EBV positive DLBCL of the elderly]] |
| − | :DLBCL associated with chronic inflammation | + | :[[DLBCL associated with chronic inflammation]] |
| − | :Lymphomatoid granulomatosis | + | :[[Lymphomatoid granulomatosis]] |
| − | :Primary mediastinal (thymic) large B-cell lymphoma | + | :[[Primary mediastinal (thymic) large B-cell lymphoma]] |
| − | :Intravascular large B-cell lymphoma | + | :[[Intravascular large B-cell lymphoma]] |
| − | :ALK positive large B-cell lymphoma | + | :[[ALK positive large B-cell lymphoma]] |
| − | :Plasmablastic lymphoma | + | :[[Plasmablastic lymphoma]] |
| − | :Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease | + | :[[Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease]] |
| − | :Primary effusion lymphoma | + | :[[Primary effusion lymphoma]] |
| − | :Burkitt lymphoma | + | :[[Burkitt lymphoma]] |
| − | :B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma | + | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma]] |
| − | :B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma | + | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Mature T- and NK-cell neoplasms''' | + | '''[[Mature T- and NK-cell neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :T-cell prolymphocytic leukaemia | + | :[[T-cell prolymphocytic leukaemia]] |
| − | :T-cell large granular lymphocytic leukaemia | + | :[[T-cell large granular lymphocytic leukaemia]] |
| − | :Chronic lymphoproliferative disorder of NK cells | + | :[[Chronic lymphoproliferative disorder of NK cells]] |
| − | :Aggressive NK cell leukaemia | + | :[[Aggressive NK cell leukaemia]] |
| − | :Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood | + | :[[Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood]] |
| − | :Systemic EBV+ T-cell lymphoproliferative disease of childhood | + | :[[Systemic EBV+ T-cell lymphoproliferative disease of childhood]] |
| − | :Hydroa vacciniforme-like lymphoma | + | :[[Hydroa vacciniforme-like lymphoma]] |
| − | :Adult T-cell leukaemia/lymphoma | + | :[[Adult T-cell leukaemia/lymphoma]] |
| − | :Extranodal NK/T-cell lymphoma, nasal type | + | :[[Extranodal NK/T-cell lymphoma, nasal type]] |
| − | :Enteropathy-associated T-cell lymphoma | + | :[[Enteropathy-associated T-cell lymphoma]] |
| − | :Hepatosplenic T-cell lymphoma | + | :[[Hepatosplenic T-cell lymphoma]] |
| − | :Subcutaneous panniculitis-like T-cell lymphoma | + | :[[Subcutaneous panniculitis-like T-cell lymphoma]] |
| − | :Mycosis fungoides | + | :[[Mycosis fungoides]] |
| − | :Sézary syndrome | + | :[[Sézary syndrome]] |
| − | :Primary cutaneous CD30 positive T-cell lymphoproliferative disorders | + | :[[Primary cutaneous CD30 positive T-cell lymphoproliferative disorders]] |
| − | :Primary cutaneous peripheral T-cell lymphomas, rare subtypes | + | :[[Primary cutaneous peripheral T-cell lymphomas, rare subtypes]] |
| − | :Primary cutaneous gamma-delta T-cell lymphoma | + | :[[Primary cutaneous gamma-delta T-cell lymphoma]] |
| − | :Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma | + | :[[Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
| − | :Primary cutaneous CD4 positive small/medium T-cell lymphoma | + | :[[Primary cutaneous CD4 positive small/medium T-cell lymphoma]] |
| − | :Peripheral T-cell lymphoma, NOS | + | :[[Peripheral T-cell lymphoma, NOS]] |
| − | :Angioimmunoblastic T-cell lymphoma | + | :[[Angioimmunoblastic T-cell lymphoma]] |
| − | :Anaplastic large cell lymphoma, ALK positive | + | :[[Anaplastic large cell lymphoma, ALK positive]] |
| − | :Anaplastic large cell lymphoma, ALK negative | + | :[[Anaplastic large cell lymphoma, ALK negative]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Hodgkin lymphoma''' | + | '''[[Hodgkin lymphoma]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Nodular lymphocyte predominant Hodgkin lymphoma | + | :[[Nodular lymphocyte predominant Hodgkin lymphoma]] |
| − | :Classical Hodgkin lymphoma | + | :[[Classical Hodgkin lymphoma]] |
| − | :Nodular sclerosis classical Hodgkin lymphoma | + | :[[Nodular sclerosis classical Hodgkin lymphoma]] |
| − | :Mixed cellularity classical Hodgkin lymphoma | + | :[[Mixed cellularity classical Hodgkin lymphoma]] |
| − | :Lymphocyte-rich classical Hodgkin lymphoma | + | :[[Lymphocyte-rich classical Hodgkin lymphoma]] |
| − | :Lymphocyte-depleted classical Hodgkin lymphoma | + | :[[Lymphocyte-depleted classical Hodgkin lymphoma]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Immunodeficiency-associated lymphoproliferative disorders''' | + | '''[[Immunodeficiency-associated lymphoproliferative disorders]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Lymphoproliferative diseases associated with primary immune disorders | + | :[[Lymphoproliferative diseases associated with primary immune disorders]] |
| − | :Lymphomas associated with HIV infection | + | :[[Lymphomas associated with HIV infection]] |
| − | :Post-transplant lymphoproliferative disorders (PTLD) | + | :[[Post-transplant lymphoproliferative disorders (PTLD)]] |
| − | :Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD | + | :[[Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD]] |
| − | :Polymorphic PTLD | + | :[[Polymorphic PTLD]] |
| − | :Monomorphic PTLD | + | :[[Monomorphic PTLD]] |
| − | :Classical Hodgkin lymphoma type PTLD | + | :[[Classical Hodgkin lymphoma type PTLD]] |
| − | :Other iatrogenic immunodeficiency-associated lymphoproliferative disorders | + | :[[Other iatrogenic immunodeficiency-associated lymphoproliferative disorders]] |
</div> | </div> | ||
</div> | </div> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| − | '''Histiocytic and dendritic cell neoplasms''' | + | '''[[Histiocytic and dendritic cell neoplasms]]''' |
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
| − | :Histiocytic sarcoma | + | :[[Histiocytic sarcoma]] |
| − | :Tumours derived from Langerhans cells | + | :[[Tumours derived from Langerhans cells]] |
| − | :Langerhans cell histiocytosis | + | :[[Langerhans cell histiocytosis]] |
| − | :Langerhans cell sarcoma | + | :[[Langerhans cell sarcoma]] |
| − | :Interdigitating dendritic cell sarcoma | + | :[[Interdigitating dendritic cell sarcoma]] |
| − | :Follicular dendritic cell sarcoma | + | :[[Follicular dendritic cell sarcoma]] |
| − | :Other rare dendritic cell tumours | + | :[[Other rare dendritic cell tumours]] |
| − | :Disseminated juvenile xanthogranuloma | + | :[[Disseminated juvenile xanthogranuloma]] |
| + | </div> | ||
| + | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
== Miscellaneous Cancer Types == | == Miscellaneous Cancer Types == | ||
| + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
| + | '''Miscellaneous Tumors''' | ||
| + | <div class="mw-collapsible-content"> | ||
: [[Acute Lymphoblastic Leukaemia (ALL)]] | : [[Acute Lymphoblastic Leukaemia (ALL)]] | ||
: [[Acute Myeloid Leukaemia (AML)]] | : [[Acute Myeloid Leukaemia (AML)]] | ||
| − | ::[[Acute | + | ::[[HAEM5:Acute megakaryoblastic leukaemia]] |
: [[Adrenal cortical carcinoma]] | : [[Adrenal cortical carcinoma]] | ||
: [[Anal Cancer]] | : [[Anal Cancer]] | ||
| Line 1,184: | Line 1,215: | ||
: [[Vaginal Cancer]] | : [[Vaginal Cancer]] | ||
: [[Vulval Cancer]] | : [[Vulval Cancer]] | ||
| + | </div> | ||
| + | </div> | ||
Latest revision as of 13:56, 12 December 2023
These classifications are based on WHO/IARC guidelines. See [1] for further details.
Common Adult Cancers
Common Pediatric Cancers
WHO Classification of Tumours of the Central Nervous System (2016)
CNS Tumors
Diffuse astrocytic and oligodendroglial tumors
- Diffuse astrocytoma, IDH-mutant
- Gemistocytic astrocytoma, IDH-mutant
- Diffuse astrocytoma, IDH-wildtype
- Diffuse astrocytoma, NOS
- Anaplastic astrocytoma, IDH-mutant
- Anaplastic astrocytoma, IDH-wildtype
- Anaplastic astrocytoma, NOS
- Glioblastoma, IDH-wildtype
- Giant cell glioblastoma
- Gliosarcoma
- Epithelioid glioblastoma
- Glioblastoma, IDH-mutant
- Glioblastoma, NOS
- Diffuse midline glioma, H3 K27M–mutant
- Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
- Oligodendroglioma, NOS 69
- Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted
- Anaplastic oligodendroglioma, NOS
- Oligoastrocytoma, NOS
- Anaplastic oligoastrocytoma, NOS
Other astrocytic tumors
- Pilocytic astrocytoma
- Pilomyxoid astrocytoma
- Subependymal giant cell astrocytoma
- Pleomorphic xanthoastrocytoma
- Anaplastic pleomorphic xanthoastrocytoma
Ependymal tumors
- Subependymoma
- Myxopapillary ependymoma
- Ependymoma
- Papillary ependymoma
- Clear cell ependymoma
- Tanycytic ependymoma
- Ependymoma, RELA fusion–positive
- Anaplastic ependymoma
Other gliomas
- Chordoid glioma of the third ventricle
- Angiocentric glioma
- Astroblastoma
Choroid plexus tumors
- Choroid plexus papilloma
- Atypical choroid plexus papilloma
- Choroid plexus carcinoma
Neuronal and mixed neuronal–glial tumors
- Dysembryoplastic neuroepithelial tumour
- Gangliocytoma
- Ganglioglioma
- Anaplastic ganglioglioma
- Dysplastic cerebellar gangliocytoma (Lhermitte–Duclos disease)
- Desmoplastic infantile astrocytoma and ganglioglioma
- Papillary glioneuronal tumour
- Rosette-forming glioneuronal tumour
- Diffuse leptomeningeal glioneuronal tumour
- Central neurocytoma
- Extraventricular neurocytoma
- Cerebellar liponeurocytoma
- Paraganglioma
Tumors of the pineal region
- Pineocytoma
- Pineal parenchymal tumour of intermediate differentiation
- Pineoblastoma
- Papillary tumour of the pineal region
Embryonal tumors
- Medulloblastoma
- Medulloblastoma, NOS
- Medulloblastomas, genetically defined
- Medulloblastoma, WNT-activated
- Medulloblastoma, SHH-activated and TP53-mutant
- Medulloblastoma, SHH-activated and TP53-wildtype
- Medulloblastoma, non-WNT/non-SHH
- Medulloblastomas, histologically defined
- Medulloblastoma, classic
- Desmoplastic/nodular medulloblastoma
- Medulloblastoma with extensive nodularity
- Large cell / anaplastic medulloblastoma
- Embryonal tumour with multilayered rosettes, C19MC-altered
- Embryonal tumour with multilayered rosettes, NOS
- Other CNS embryonal tumors
- Medulloepithelioma
- CNS neuroblastoma
- CNS ganglioneuroblastoma
- CNS embryonal tumour, NOS
- Atypical teratoid/rhabdoid tumour
- CNS embryonal tumour with rhabdoid features
Tumors of the cranial and paraspinal nerves
- Schwannoma
- Cellular schwannoma
- Plexiform schwannoma
- Melanotic schwannoma
- Neurofibroma
- Atypical neurofibroma
- Plexiform neurofibroma
- Perineurioma
- Hybrid nerve sheath tumors
- Malignant peripheral nerve sheath tumour (MPNST)
- MPNST with divergent differentiation
- Epithelioid MPNST
- MPNST with perineurial differentiation
Meningiomas
- Meningioma
- Meningioma variants
- Meningothelial meningioma
- Fibrous meningioma
- Transitional meningioma
- Psammomatous meningioma
- Angiomatous meningioma
- Microcystic meningioma
- Secretory meningioma
- Lymphoplasmacyte-rich meningioma
- Metaplastic meningioma
- Chordoid meningioma
- Clear cell meningioma
- Atypical meningioma
- Papillary meningioma
- Rhabdoid meningioma
- Anaplastic (malignant) meningioma
Mesenchymal, non-meningothelial tumors
- Solitary fibrous tumour / haemangiopericytoma
- Haemangioblastoma
- Haemangioma
- Epithelioid haemangioendothelioma
- Angiosarcoma
- Kaposi sarcoma
- Ewing sarcoma / peripheral primitive
- Neuroectodermal tumour
- Lipoma
- Angiolipoma
- Hibernoma
- Liposarcoma
- Desmoid-type fibromatosis
- Myofibroblastoma
- Inflammatory myofibroblastic tumour
- Benign fibrous histiocytoma
- Fibrosarcoma
- Undifferentiated pleomorphic sarcoma / malignant
- Fibrous histiocytoma
- Leiomyoma
- Leiomyosarcoma
- Rhabdomyoma
- Rhabdomyosarcoma
- Chondroma
- Chondrosarcoma
- Osteoma
- Osteochondroma
- Osteosarcoma
Melanocytic tumors
- Meningeal melanocytosis
- Meningeal melanomatosis
- Meningeal melanocytoma
- Meningeal melanoma
Lymphomas
- Diffuse large B-cell lymphoma of the CNS
- Corticoid-mitigated lymphoma
- Sentinel lesions
- Immunodeficiency-associated CNS lymphomas
- AIDS-related diffuse large B-cell lymphoma
- EBV+ diffuse large B-cell lymphoma, NOS
- Lymphomatoid granulomatosis
- Intravascular large B-cell lymphoma
- Miscellaneous rare lymphomas in the CNS
- Low-grade B-cell lymphomas
- T-cell and NK/T-cell lymphomas
- Anaplastic large cell lymphoma (ALK+/ALK–)
- MALT lymphoma of the dura
Histiocytic tumors
- Langerhans cell histiocytosis
- Erdheim–Chester disease
- Rosai–Dorfman disease
- Juvenile xanthogranuloma
- Histiocytic sarcoma
Germ cell tumors
- Germinoma
- Embryonal carcinoma
- Yolk sac tumour
- Choriocarcinoma
- Teratoma
- Mature teratoma
- Immature teratoma
- Teratoma with malignant transformation
- Mixed germ cell tumour
Familial tumour syndromes
- Neurofibromatosis type 1
- Neurofibromatosis type 2
- Schwannomatosis
- Von Hippel–Lindau disease
- Tuberous sclerosis
- Li–Fraumeni syndrome
- Cowden syndrome
- Turcot syndrome
- Mismatch repair cancer syndrome
- Familial adenomatous polyposis
- Naevoid basal cell carcinoma syndrome
- Rhabdoid tumour predisposition syndrome
Tumors of the sellar region
- Craniopharyngioma
- Adamantinomatous craniopharyngioma
- Papillary craniopharyngioma
Granular cell tumour of the sellar region Pituicytoma 332 Spindle cell oncocytoma
Metastatic tumors
WHO Classification of Pathology and Genetics of Head and Neck Tumors
Head and Neck Tumors
Nasal cavity and paranasal sinuses
- Malignant epithelial tumours
- Squamous cell carcinoma
- Lymphoepithelial carcinoma
- Sinonasal undifferentiated carcinoma
- Adenocarcinoma
- Salivary gland-type carcinomas
- Neuroendocrine tumours
- Benign epithelial tumours
- Schneiderian papillomas
- Respiratory epithelial adenomatoid hamartoma
- Salivary gland-type adenomas
- Soft tissue tumours
- Malignant soft tissue tumours
- Borderline and LMP tumours
- Benign soft tissue tumours
- Tumours of bone and cartilage
- Malignant tumours
- Benign tumours
- Haematolymphoid tumours
- Neuroectodermal tumours
- Germ cell tumours
- Secondary tumours
Nasopharynx
- Malignant epithelial tumours
- Nasopharyngeal carcinoma
- Papillary adenocarcinoma
- Salivary gland-type carcinomas
- Benign epithelial tumours
- Nasopharyngeal angiofibroma
- Haematolymphoid tumours
- Tumours of bone and cartilage
- Secondary tumours
Hypopharynx, larynx and trachea
- Malignant epithelial tumours
- Squamous cell carcinoma
- Verrucous carcinoma
- Basaloid squamous cell carcinoma
- Papillary squamous cell carcinoma
- Spindle cell carcinoma
- Acantholytic squamous cell carcinoma
- Adenosquamous carcinoma
- Lymphoepithelial carcinoma
- Giant cell carcinoma
- Malignant salivary gland-type tumours
- Neuroendocrine tumours
- Adenocarcinoma, N.O.S.
- Myoepithelial carcinoma
- Carcinoma ex pleomorphic adenoma
- Carcinosarcoma
- Metastasizing pleomorphic adenoma
- Squamous cell carcinoma
- Small cell carcinoma
- Large cell carcinoma
- Lymphoepithelial carcinoma
- Sialoblastoma Benign epithelial tumours
- Pleomorphic adenoma
- Myoepithelioma
- Basal cell adenoma
- Warthin tumour
- Oncocytoma
- Canalicular adenoma
- Sebaceous adenoma
- Lymphadenomas
- Ductal papillomas
- Cystadenoma
- Soft tissue tumours
- Haemangioma
- Haematolymphoid tumours
- Secondary tumours
Odontogenic tumours
- Odontogenic carcinomas
- Ameloblastic carcinomas
- Primary intraosseous squamous cell carcinomas
- Clear cell odontogenic carcinoma
- Ghost cell odontogenic carcinoma
- Odontogenic sarcomas
- Benign tumours
- Odontogenic epithelium with mature fibrous stroma,
- without odontogenic ectomesenchyme
- Ameloblastomas
- Squamous odontogenic tumour
- Calcifying epithelial odontogenic tumour
- Adenomatoid odontogenic tumour
- Keratocystic odontogenic tumour
- Odontogenic epithelium with odontogenic ectome-
- senchyme, with or without tissue formation
- Ameloblastic fibroma / fibrodentinoma
- Ameloblastic fibro-odontoma
- Odontoma, complex type
- Odontoma, compound type
- Odontoameloblastoma
- Calcifying cystic odontogenic tumour
- Dentinogenic ghost cell tumour
- Mesenchyme and/or odontogenic ectome- senchyme, with or without odontogenic epithelium
- Odontogenic fibroma
- Odontogenic myxoma / myxofibroma
- Cementoblastoma
- Epithelial precursor lesions
- Benign epithelial tumours
- Papilloma / papillomatosis
- Benign salivary gland-type tumours
- Malignant soft tissue tumours
- Inflammatory myofibroblastic tumour
- Benign soft tissue tumours
- Haematolymphoid tumours
- Tumours of bone and cartilage
- Mucosal malignant melanoma
- Secondary tumours
Oral cavity and oropharynx
- Malignant epithelial tumours
- Squamous cell carcinoma
- Lymphoepithelial carcinoma
- Epithelial precursor lesions
- Proliferative verrucous leukoplakia
- Precancerous conditions
- Benign epithelial tumours
- Papillomas
- Granular cell tumour
- Keratoacanthoma
- Papillary hyperplasia
- Median rhomboid glossitis
- Salivary gland tumours
- Kaposi sarcoma
- Lymphangioma
- Ectomesenchymal chondromyxoid tumour
- Focal oral mucinosis
- Congenital granular cell epulis
- Haematolymphoid tumours
- Malignant melanoma
- Secondary tumours
Salivary glands
- Malignant epithelial tumours
- Acinic cell carcinoma
- Mucoepidermoid carcinoma
- Adenoid cyctic carcinoma
- Polymorphous low-grade adenocarcinoma
- Epithelial-myoepithelial carcinoma
- Clear cell carcinoma, N.O.S.
- Basal cell adenocarcinoma
- Malignant sebaceous tumours
- Cystadenocarcinoma
- Low-grade cribriform cystadenocarcinoma
- Mucinous adenocarcinoma
- Oncocytic carcinoma
- Salivary duct carcinoma
- Bone related lesions
- Ossifying fibroma
- Fibrous dysplasia
- Osseous dysplasias
- Central giant cell lesion
- Cherubism
- Aneurysmal bone cyst
- Simple bone cyst
Ear
- External ear
- Tumours of ceruminous glands
- Cylindroma
- Squamous cell carcinoma
- Embryonal rhabdomyosarcoma
- Fibrous dysplasia
- Osteoma and exostosis
- Angiolymphoid hyperplasia with eosinophilia
- Kimura disease
- Idiopathic pseudocystic chondromalacia
- Chondrodermatits nodularis chronica helicis
- Middle ear
- Cholesterol granuloma and cholesteatoma
- Adenoma
- Papillary tumours
- Choristoma
- Squamous cell carcinoma
- Meningioma
- Inner ear
- Vesticular schwannoma
- Neurofibromatosis type 2
- Lipoma of the internal auditory canal
- Haemangioma
- Endolymphatic sac tumour
- Haematolymphoid tumours
- Langerhans cell histiocytosis
- Secondary tumours
Paraganglionic system
- Carotid body paraganglioma
- Jugulotympanic paraganglioma
- Vagal paraganglioma
- Laryngeal paraganglioma
WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016)
WHO Classification of Tumors of Endocrine Organs
Endocrine Tumors
Tumors of the pituitary
- Pituitary adenomas
- Growth hormone producing adenoma
- Prolactin producing adenoma
- Thyrotropin producing adenoma
- ACTH producing adenoma
- Gonadotropin producing adenoma
- Null cell adenoma
- Plurihormonal adenoma
- Pituitary carcinoma
- Gangliocytoma
- Mesenchymal tumors
- Chordoma
- Meningioma
- Granular cell tumour
- Secondary tumors
Tumors of the thyroid and parathyroid
- Papillary carcinoma
- Follicular carcinoma
- Poorly differentiated carcinoma
- Undifferentiated (anaplastic) carcinoma
- Squamous cell carcinoma
- Mucoepidermoid carcinoma
- Sclerosing mucoepidermoid carcinomawith eosinophilia
- Mucinous carcinoma
- Medullary thyroid carcinoma
- Mixed medullary and follicular cell carcinoma
- Spindle cell tumour with thymus-like differentiation
- Carcinoma showing thymus-like differentiation
- Follicular adenoma
- Hyalinizing trabecular tumour
- Teratoma
- Primary lymphoma and plasmacytoma
- Ectopic thymoma
- Angiosarcoma
- Smooth muscle tumors
- Peripheral nerve sheath tumors
- Paraganglioma
- Solitary fibrous tumour
- Rosai-Dorfman disease
- Follicular dendritic cell tumour
- Langerhans cell histiocytosis
- Secondary tumors of the thyroid
- Parathyroid carcinoma
- Parathyroid adenoma
- Secondary tumors of the parathyroid
Tumors of the adrenal gland
- Adrenal cortical carcinoma
- Adrenal cortical adenoma
- Malignant adrenal phaeochromocytoma
- Benign phaeochromocytoma
- Composite phaeochromocytoma or paraganglioma
- Extra-adrenal paraganglioma
- Carotid body, jugulotympanic, vagal, laryngeal, aortico-pulmonary
- Gangliocytic, cauda equina, orbital, nasopharyngeal
- Extra-adrenal sympathetic paraganglioma
- Superior and inferior paraaortic
- Cervical, intrathoracic and urinary bladder
- Adenomatoid tumour
- Sex cord-stromal tumour
- Adrenal soft tissue and germ cell tumors
- Secondary tumors
Tumors of the endocrine pancreas
- Insulinoma
- Glucagonoma
- Somatostatinoma
- Gastrinoma
- VIPoma
- Serotonin secreting tumour
- ACTH and other ectopic hormone producing tumors
- Non-functioning tumors and microadenomas
- Mixed exocrine-endocrine carcinomas
- Poorly differentiated endocrine carcinoma
Inherited tumour syndromes
- Multiple endocrine neoplasia type 2
- Multiple endocrine neoplasia type 1
- Hyperparathyroidism-Jaw tumour syndrome
- Von Hippel-Lindau syndrome (VHL)
- Familial paraganglioma-phaeochromocytoma syndromes caused by SDHB, SDHC and SDHD mutations
- Neurofibromatosis type 1
- Carney complex
- McCune-Albright syndrome
- Familial non-medullary thyroid cancer
WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart (2015)
WHO Classification of Tumors of Female Reproductive Organs (2014)
WHO Classification of Tumors of Soft Tissue and Bone (2013)
WHO Classification of Tumors of the Breast (2012)
Breast Tumors
Invasive carcinoma of no special type (invasive ductal carcinoma)
Special subtypes
- Invasive lobular carcinoma
- Tubular carcinoma and cribriform carcinoma
- Carcinoma with medullary features
- Metaplastic carcinoma
- Carcinoma with apocrine differentiation
- Salivary gland/skin adnexal type tumors
- Adenoid cystic carcinoma
- Mucoepidermoid carcinoma
- Polymorphous carcinoma
- Mucinous carcinoma and Carcinoma with signet-ring-cell differentiation
- Carcinoma with neuroendocrine features
- Invasive papillary carcinoma
- Invasive micropapillary carcinoma
- Inflammatory carcinoma
- Bilateral breast carcinoma and non-synchronous breast carcinoma
- Secretory carcinoma
- Oncocytic carcinoma
- Sebaceous carcinoma
- Lipid-rich carcinoma
- Glycogen-rich clear cell carcinoma
- Acinic cell carcinoma
Lobular neoplasia
Intraductal proliferative lesions
- Usual ductal hyperplasia
- Columnar cell lesions
- Atypical ductal hyperplasia
- Ductal carcinoma in situ
Microinvasive carcinoma
Intraductal papillary lesions
Benign epithelial proliferations
- Adenosis, sclerosing adenosis and apocrine adenosis
- Microglandular adenosis,atypical microglandular adenosis and microglandular adenosis with carcinoma
- Radial scar and complex sclerosing lesion
- Tubular adenoma
- Lactating adenoma
- Apocrine adenoma
- Ductal adenoma
- Pleomorphic adenoma
Myoepithelial and epithelial–myoepithelial lesions
Mesenchymal tumors
- Nodular fasciitis
- Benign vascular lesions
- Pseudoangiomatous stromal hyperplasia
- Myofibroblastoma
- Desmoid-type fibromatosis
- Inflammatory myofibroblastic tumour
- Lipoma
- Granular cell tumour and benign peripheral
- nerve-sheath tumour
- Angiosarcoma
- Liposarcoma
- Rhabdomyosarcoma
- Osteosarcoma
- Leiomyoma and leiomyosarcoma
Fibroepithelial tumors
- Fibroadenoma
- Phyllodes tumour
- Hamartoma
Tumors of the nipple
- Nipple adenoma
- Syringomatous tumour
- Paget disease
Lymphoid and haematopoietic tumors
- Diffuse large B-cell lymphoma
- Burkitt lymphoma
- T-cell lymphoma
- Extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue
- Follicular lymphoma
Metastases of extramammary malignancies to the breast
Tumors of the male breast
Genetic susceptibility: inherited syndromes
- Inherited syndromes associated with an increased risk of breast cancer: Introduction
- BRCA1 symdrome and BRCA2 syndrome
- Li-Fraumeni syndrome
- Ataxia telangiectasia syndrome
- Cowden syndrome
- Lynch syndrome
- Other breast cancer-predisposing genes
WHO Classification of Tumours of the Digestive System (2010)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008)
Hematological and Lymphoid Neoplasms
- Chronic myelogenous leukaemia, BCR-ABL1 positive
- Chronic neutrophilic leukaemia
- Polycythaemia vera
- Primary myelofibrosis
- Essential thrombocythaemia
- Chronic eosinophilic leukaemia, NOS
- HAEM4:Mastocytosis
- Cutaneous mastocytosis
- Systemic mastocytosis
- Mast cell leukaemia
- Mast cell sarcoma
- Extracutaneous mastocytoma
- Myeloproliferative neoplasm, unclassifiable
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1
- Myelodysplastic syndromes/neoplasms, overview
- Refractory cytopenia with unilineage dysplasia
- Refractory anaemia with ring sideroblasts
- Refractory cytopenia with multilineage dysplasia
- Refractory anaemia with excess blasts
- Myelodysplastic syndrome with isolated del(5q)
- Myelodysplastic syndrome, unclassifiable
- Childhood myelodysplastic syndrome
- Refractory cytopenia of childhood
Acute myeloid leukaemia (AML) and related precursor neoplasms
- AML with recurrent genetic abnormalities
- AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
- AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
- Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA
- AML with t(9;11)(p22;q23); MLLT3-MLL
- AML with t(6;9)(p23;q34); DEK-NUP214
- AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1
- AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1
- AML with mutated NPM1
- AML with mutated CEBPA
- AML with myelodysplasia-related changes
- Therapy-related myeloid neoplasms
- Acute myeloid leukaemia, NOS
- AML with minimal differentiation
- AML without maturation
- AML with maturation
- Acute myelomonocytic leukaemia
- Acute monoblastic and monocytic leukaemia
- Acute erythroid leukaemia
- Acute megakaryoblastic leukaemia
- Acute basophilic leukaemia
- Acute panmyelosis with myelofibrosis
- Myeloid sarcoma
- Myeloid proliferations related to Down syndrome
- Transient abnormal myelopoiesis
- Myeloid leukaemia associated with Down syndrome
- Blastic plasmacytoid dendritic cell neoplasm
Acute leukaemias of ambiguous lineage
- Acute undifferentiated leukaemia
- Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1
- Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged
- Mixed phenotype acute leukaemia, B/myeloid, NOS 152
- Mixed phenotype acute leukaemia, T/myeloid, NOS 153
- Mixed phenotype acute leukaemia, NOS - rare types
- Other ambiguous lineage leukaemias
- Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma
- B lymphoblastic leukaemia/lymphoma, NOS
- B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities
- B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1
- B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged
- B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
- B lymphoblastic leukaemia/lymphoma with hyperdiploidy
- B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)
- B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
- B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)
- T lymphoblastic leukaemia/lymphoma
- Chronic lymphocytic leukaemia /small lymphocytic lymphoma
- B-cell prolymphocytic leukaemia
- Splenic marginal zone lymphoma
- Hairy cell leukaemia
- Splenic B-cell lymphoma/leukaemia, unclassifiable
- Splenic diffuse red pulp small B-cell lymphoma
- Hairy cell leukaemia-variant
- Lymphoplasmacytic lymphoma
- Heavy chain diseases
- Gamma heavy chain disease
- Mu heavy chain disease
- Alpha heavy chain disease
- Plasma cell neoplasms
- Monoclonal gammopathy of undetermined significance (MGUS)
- Plasma cell myeloma
- Solitary plasmacytoma of bone
- Extraosseous plasmacytoma
- Monoclonal immunoglobulin deposition diseases
- Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)
- Nodal marginal zone lymphoma
- Follicular lymphoma
- Primary cutaneous follicle centre lymphoma
- Mantle cell lymphoma
- Diffuse large B-cell lymphoma (DLBCL), NOS
- T cell/histiocyte-rich large B-cell lymphoma
- Primary DLBCL of the CNS
- Primary cutaneous DLBCL, leg type
- EBV positive DLBCL of the elderly
- DLBCL associated with chronic inflammation
- Lymphomatoid granulomatosis
- Primary mediastinal (thymic) large B-cell lymphoma
- Intravascular large B-cell lymphoma
- ALK positive large B-cell lymphoma
- Plasmablastic lymphoma
- Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
- Primary effusion lymphoma
- Burkitt lymphoma
- B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma
- B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma
Mature T- and NK-cell neoplasms
- T-cell prolymphocytic leukaemia
- T-cell large granular lymphocytic leukaemia
- Chronic lymphoproliferative disorder of NK cells
- Aggressive NK cell leukaemia
- Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood
- Systemic EBV+ T-cell lymphoproliferative disease of childhood
- Hydroa vacciniforme-like lymphoma
- Adult T-cell leukaemia/lymphoma
- Extranodal NK/T-cell lymphoma, nasal type
- Enteropathy-associated T-cell lymphoma
- Hepatosplenic T-cell lymphoma
- Subcutaneous panniculitis-like T-cell lymphoma
- Mycosis fungoides
- Sézary syndrome
- Primary cutaneous CD30 positive T-cell lymphoproliferative disorders
- Primary cutaneous peripheral T-cell lymphomas, rare subtypes
- Primary cutaneous gamma-delta T-cell lymphoma
- Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
- Primary cutaneous CD4 positive small/medium T-cell lymphoma
- Peripheral T-cell lymphoma, NOS
- Angioimmunoblastic T-cell lymphoma
- Anaplastic large cell lymphoma, ALK positive
- Anaplastic large cell lymphoma, ALK negative
Immunodeficiency-associated lymphoproliferative disorders
- Lymphoproliferative diseases associated with primary immune disorders
- Lymphomas associated with HIV infection
- Post-transplant lymphoproliferative disorders (PTLD)
- Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD
- Polymorphic PTLD
- Monomorphic PTLD
- Classical Hodgkin lymphoma type PTLD
- Other iatrogenic immunodeficiency-associated lymphoproliferative disorders
Miscellaneous Cancer Types
Miscellaneous Tumors
- Acute Lymphoblastic Leukaemia (ALL)
- Acute Myeloid Leukaemia (AML)
- Adrenal cortical carcinoma
- Anal Cancer
- Angiomatoid Fibrous Histiocytoma
- Bile duct Cancer
- Bladder Cancer
- Bladder: Squamous cell carcinoma
- Bladder: Urothelial carcinomas
- Bone Cancer
- Adamantinoma
- Aneurysmal bone cysts
- Angiosarcoma
- Chondroblastoma
- Chondroma
- Chondromyxoid fibroma
- Chondrosarcoma
- Conventional Osteosarcoma
- Dedifferentiated chondrosarcoma
- Enchondroma
- Epithelioid hemangioendothelioma
- Fibrous dysplasia of the bone
- Giant cell tumour
- Haemangiomas and related lesions
- Osteoblastoma
- Osteochondroma
- Osteoid Osteoma
- Osteoma
- Osteosarcoma
- Periosteal chondroma
- Vascular Tumours
- Bowel Cancer
- Brain tumours
- Breast Cancer
- Carcinoid Tumors
- Central Nervous System: Glioma
- Cervical Cancer
- Chordoma
- Choriocarcinoma
- Chronic lymphocytic leukaemia (CLL)
- Chronic myeloid leukaemia (CML)
- Clear Cell Hidradenoma of the Skin (CCH)
- Colorectal Cancer
- Dermatofibrosarcoma Protuberans
- Desmoid-type fibromatosis
- Digestive organs: Carcinoma of the gallbladder and extrahepatic bile ducts
- Digestive organs: Liver: Combined hepatocellular and cholangiocarcinoma
- Endometrial Cancer
- Esophagus
- Eye Cancer
- Eye tumors: an overview
- Fallopian tube tumors: an overview
- Fibrogenesis imperfecta ossium
- Gallbladder Cancer
- Gastric Cancer
- Gastric Tumors: an overview
- Gestational trophoblastic tumours (GTT)
- Hairy cell leukaemia
- Head and Neck Cancer Squamous cell carcinoma (HNSCC)
- Ear: Endolymphatic Sac Tumor (ELST)
- Epidermoid carcinoma
- Iris Hamartomas
- Odontogenic tumor: Ameloblastoma
- Oral leukoplakia
- Pleomorphic salivary gland adenoma with ins(8)(q12;q11q11) TCEA1/PLAG1
- Pleomorphic salivary gland adenoma with inv(8)(q12q12) CHCHD7/PLAG1
- Retinoblastoma
- Retinoma
- Salivary gland tumors: an overview
- Thymus
- Heart
- Hodgkin lymphoma
- Inflammatory fibroid polyps
- Intrahepatic cholangiocarcinoma
- Kidney Cancer
- Laryngeal Cancer
- Liver adenoma
- Liver Cancer
- Lung Cancer
- Lymphangioleiomyoma
- Lymphangioleiomyomatosis
- Lymphoma
- Melanoma skin Cancer
- Mesothelioma
- Molar pregnancy
- Mouth and oropharyngeal Cancer
- Multiple Myeloma
- Nasal and sinus Cancers
- Nasopharyngeal Cancer
- Nervous system tumours
- Neuroendocrine tumors
- Neurofibroma
- Non Hodgkin lymphoma (NHL)
- Oesophageal Cancer
- Optic Nerve Glioma
- Oral squamous cell carcinoma
- Ovarian Cancer
- Pancreatic Cancer
- Penile Cancer
- Pericytoma
- Pituitary Adenomas
- Posterior uveal melanoma
- Prostate Cancer
- Rectal Cancer
- Rhabdoid tumor
- Salivary gland Cancer
- Skin Cancer
- Smooth muscle
- Soft tissue tumors
- Aggressive angiomyxoma
- Alveolar rhabdomyosarcoma
- Alveolar soft part sarcoma
- Angiofibroma
- Clear cell sarcoma
- Desmoplastic small round cell tumor
- Elastofibroma
- Embryonal rhabdomyosarcoma
- Ewing's tumors/Primitive neurectodermal tumors (PNET)
- Extraskeletal myxoid chondrosarcoma
- Extraskeletal osteosarcoma
- Inflammatory myofibroblastic tumor
- Lipoblastoma
- Lipoma / benign lipomatous tumors
- Lipoma: Chondroid lipoma
- Liposarcoma / malignant lipomatous tumors
- Liposarcoma: Myxoid liposarcoma
- Low grade fibromyxoid sarcoma
- Malignant Myoepithelioma
- Rhabdomyosarcoma
- Soft Tissue Leiomyosarcoma
- Soft tissue chondroma
- Synovial sarcoma
- Hibernomas
- Squamous cell Cancer
- Stomach Cancer
- Testicular Cancer
- Thyroid Cancer
- Uterine Cancer
- Vulva and Vagina tumors
- Vaginal Cancer
- Vulval Cancer